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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A194BtgI did not show any signiﬁcant (p>0.05) association with these clin-
ical features nor with WOMAC pain. The association of CALM-1 gene
with radiological severity was signiﬁcant in all the three SNPs studied;
CALM-1 ApaLI (F¼ 9.36, p<0.001), CALM-1 ApeKI (p<0.001) and CALM-
1 rs2300496 (F¼ 3.96, p<0.001). Further, the Tukey test showed sig-
niﬁcantly (p<0.001) different and higher mean radiological severity in
CT and TT genotypes of CALM-1 ApaLI as compared to CC genotype; in
CALM-1 rs2300496 the mean radiological severity in CC genotype was
signiﬁcantly (p<0.05) different and higher as compared to AA genotype
and in CALM-1 ApeKI, the mean radiological severity in TG genotype
was signiﬁcantly (p<0.001) different and higher as compared to TT
genotype. However GDF-5* rs 331383 and ESR-a BtgI rs* 2228480 did
not show any signiﬁcant association with mean radiological severity.
Conclusions: In this study we found that in cases of knee osteoarthritis,
GDF-5* rs 331383 and CALM-1 ApekI genotype had signiﬁcant associ-
ation with WOMAC pain; all the three SNPs of CALM-1 genotype had
signiﬁcant association with radiological severity and ESR-a BtgI geno-
type did not show any association with either clinical or radiological
features. These ﬁnding validate our contention that genetic variants
inﬂuence knee pain and radiological changes in knee osteoarthritis and
different genotypes being responsible for the severity in these two
parameters may be responsible for the clinical and radiological dis-
cordance being reported by several authors.
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DIFFERENTIAL DNA METHYLATION AND EXPRESSION OF
INFLAMMATORY AND ZINC TRANSPORTER GENES DEFINES SUB-
GROUPS OF OSTEOARTHRITIC HIP PATIENTS
M.D. Rushton, D.A. Young, J. Loughlin, L.N. Reynard. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: Using the Inﬁnium HumanMethylation450 BeadChip (Illu-
mina), which measures the level of DNA methylation at approximately
480,000 CpG sites throughout the human genome, we have previously
shown that the cartilage DNA methylome delineates two groups, or
clusters, of osteoarthritic (OA) hip patients. These two clusters, which
we designated clusters 1 and 2, are characterized by differential
methylation of genes involved in inﬂammation. In that study we had
also analyzed a group of age-matched patients who were free of hip OA
but who had undergone hip replacement due to a neck of femur (NOF)
fracture. OA hip cluster 1 was more similar at the methylation level to
the NOF patients than was OA hip cluster 2. In this study we aimed to
investigate the two OA hip clusters in more detail to ascertain what are
the key methylation and gene expression features that distinguish
them.
Methods: Using our HumanMethylation450 BeadChip data we
searched for CpG sites that were signiﬁcantly differentially methylated
between OA hip cluster 2 and both OA hip cluster 1 and the NOF
patients (Kruskal-Wallis test, p<0.05, 10% or greater difference in
methylation). Gene ontology (GO) term analysis was used to identify
pathways hypo or hyper methylated. Gene expressionwas measured by
real time quantitative RT-PCR and relative to the housekeeping gene 18s
rRNA.
Results: We identiﬁed 10071 differentially methylated loci (DMLs), of
which 4313 were hypomethylated and 5758 were hypermethylated in
OA hip cluster 2 compared to both NOF and OA hip cluster 1. GO term
analysis revealed a striking enrichment of terms related to inﬂamma-
tion and immunity. Cluster 2 was characterized by the promoter
hypomethylation and increased expression of inﬂammation-associated
genes including TNF, IL6, CXCR2, CCL5, IL1A and CCL2 (all p-values
<0.01). Expression of these genes inversely correlated with methylation
levels at the differentially methylated CpG sites. Recently it has been
shown that elevated intracellular zinc levels are involved in the up
regulation of metalloproteinases in OA and that inﬂammatory factors
such as IL1 and IL6 regulate the ZIP group of zinc transporters. We found
that the increase in expression of the inﬂammation-associated genes in
hip cluster 2 was accompanied by an increase in the expression of
several of the zinc transporter genes including ZIP3, ZIP4, ZIP7, ZIP8,
ZIP11 and ZIP14 (all p-values <0.05). Furthermore, ZIP4, ZIP7, ZIP11 and
ZIP14 were differentially methylated between our two OA hip clusters
(all p-values <0.05). In addition the zinc responsive transcription factor
MTF1 was also up-regulated in cluster 2 (p<0.001), which was
accompanied by an increase in the expression of its downstream targets
the metalloproteinase genes MMP13 and ADAMTS5 (both p-values
<0.001).Conclusions: We have identiﬁed a sub-group of OA hip patients that is
epigenetically and transcriptionally characterized by a cartilage
inﬂammatory phenotype with concurrent differential expression of
zinc regulators. The emerging role of zinc in the induction of matrix-
degrading enzyme expression in chondrocytes has led to the suggestion
that zinc regulation could offer therapeutic opportunities in OA. Our
data supports this suggestion but very clearly highlights that this may
be particularly applicable to a sub-group of OA individuals. The iden-
tiﬁcation of sub-groups therefore enhances stratiﬁed phenotyping of
OA patients and has important implications for future therapeutic
applications. For example, the administration of anti-inﬂammatories
may be more efﬁcacious for patients who fall into cluster 2 than those
who fall into cluster 1.
304
GENOME-WIDE DNA METHYLATION STUDY OF HIP AND KNEE
CARTILAGE REVEALS EMBRYONIC ORGAN AND SKELETAL SYSTEM
MORPHOGENESIS AS MAJOR PATHWAYS INVOLVED IN
OSTEOARTHRITIS
E. Aref-Eshghi, Y. Zhang, M. Liu, P.E. Harper, G. Martin, A. Furey,
R. Green, P. Rahman, G. Zhai. Mem. Univ. of Newfoundland, St John's, NL,
Canada
Purpose: The objectives of this study were to describe the genomewide
DNA methylation changes in hip and knee osteoarthritis (OA) and to
identify novel genes and pathways involved in OA by comparing the
DNA methylome of the hip and knee osteoarthritic cartilage with those
of healthy individuals.
Methods: OA cartilage samples were collected from the tibial plateau
and femoral head articular surfaces of patients with severe OA under-
going total hip/knee replacement surgery. Healthy cartilage samples
were obtained from individuals with femoral neck fractures, but no OA.
Chondrocyte DNA methylation was assayed by Illumina Inﬁnium
HumanMethylation450 BeadChip array, allowing for the analysis of
>480,000 CpG sites. A sub-analysis was also done to compare hip and
knee OA. An independent sample T-test was conducted for each CpG
site and those sites with at least 10% methylation difference and a P-
value of <0.0001 were selected as differentially methylated regions
(DMR). DAVID v6.7 was used for the functional annotation clustering of
the DMR genes.
Results: The study population comprises 5 patients with hip OA, 6
patients with knee OA and 7 hip samples from healthy individuals. The
comparisons of hip, knee and combined hip/knee OA patients with
controls resulted in 26, 72, and 103 DMRs, respectively. The comparison
between hip and knee OA revealed 67 DMRs. The overall number of the
sites after considering the overlaps was 239, among which 151 sites
were annotated to 145 genes. 28 of these genes were reported in pre-
vious methylation studies of OA. The functional annotation clustering of
the identiﬁed genes revealed clusters signiﬁcantly enriched in skeletal
system morphogenesis (bonferroni corrected p¼8.4e-9) and develop-
ment (bonferroni corrected p¼9.0e-6), embryonic organ (bonferroni
corrected p¼1.4e-5) and skeletal system morphogenesis (bonferroni
corrected p¼9.9e-7), as well as Homeobox genes (bonferroni corrected
p¼3.1e-4). A sub-analysis after the removal of the genes differentially
methylated between hip and knee OA highlighted the same pathways
excluding Homeobox genes.
Conclusions:We demonstrated a number of CpG sites and genes across
the genome differentially methylated among OA patients and controls,
a remarkable portion of which seem to be involved in potential etiologic
mechanisms of OA. Genes involved in skeletal developmental pathways
and embryonic organ morphogenesis may be a potential area of con-
centration for future osteoarthritis genetic/epigenetic research.
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GENOME-WIDE DNA METHYLATION PROFILING OF OSTEOARTHRITIC
ARTICULAR CARTILAGE
Y. Zhang y, N. Fukui z, M. Yahata y, M. Lee y. yRIKEN, Yokohama, Japan;
zUniv. of Tokyo, Tokyo, Japan
Purpose: The aim of this study was to characterize the genome-wide
DNA methylation proﬁle of cartilage from knee joints obtained from
patients with primary osteoarthritis (OA) who underwent arthroplasty,
and providing the ﬁrst comparison of DNA methylation among the
cartilage representing early (outer lateral tibial plateaus, oLT),
